To anyone who needs a few more CLE hours before the end of the 2022, we wanted to let you know that sessions from Reed Smith’s recent Life Sciences CLE Week are now available on demand. Here are descriptions of the topics, and registration links.
The Ebb and Flow of the Law – A Year of Drug, Medical Device, and Vaccine-Related Preemption Developments | Presented by Blogger Jim Beck | Preemption is the most powerful defense in prescription medical product liability litigation. This presentation discusses significant preemption-related developments over the last twelve months, both favorable and unfavorable, in product liability litigation involving prescription drugs (including generics), medical devices, vaccines, and OTC drugs. While the emphasis will be practical – using preemption to win cases in litigation – the presentation will fit new case-law into the Supreme Court’s overall preemption framework. Click to register and view on demand.
Ethics and E-Discovery: Lessons Learned from the Alex Jones Cases and Others | Presented by Dave Cohen and Selina Coleman | The Alex Jones cases and other recent events have focused a spotlight on complying with ethical obligations in e-discovery and information governance. As both the volume and variety of electronic communication increase, identification, preservation, and production of relevant data, and protecting personal information, are a growing challenge. The Alex Jones case will serve as a starting point for discussing Model Rules 1.1, 1.6, 3.1, 3.3, and 3.4 and other recent matters where sanctions or major fines were issued relating to discovery or information governance. Join us for this ethics CLE program to learn about practical steps that practitioners can take to help ensure that they are meeting their ethical obligations and minimizing liability risks. Click to register and view on demand.
Current Trends in Today’s Pharma and Device Litigation | Presented by Shana Russo, Whitney Mayer, and Adriana Santomero | This program explores emerging product liability trends, including a rise in claims targeting over-the-counter products, lawsuits alleging less tangible damages that have a multifactorial cause, and plaintiffs recycling causation theories and mechanisms from prior litigation. In addition, this session explores the emerging role of independent laboratories and how plaintiffs are using product transportation to develop new theories of causation. We will discuss the unique issues presented by these emerging trends and potential strategies to combat them. Click to register and view on demand.
Health Care Fraud and Abuse in a Digital World | Presented by Nan Halstead and Vicki Tankle | This session covers nuanced health care fraud and abuse and privacy risks associated with digital health technologies, including electronic health records, mobile health solutions and applications, clinical decision support tools, connected devices, and more. This session is geared towards drug and device manufacturers and technology companies and provides attendees with an understanding of what constitutes digital health and health information technology; how the federal anti-kickback statute, the federal false claims act, HIPAA and other laws apply in the digital world; and best practices for compliance. Click to register and view on demand.
Warning Causation: Taxonomy and Tactics | Presented by Bloggers Steve McConnell and Rachel Weil | What must a plaintiff show to establish that an allegedly inadequate product warning caused injury? Some jurisdictions place a strict burden on plaintiffs to show that a different warning would have led to different or non-usage of the product. Other jurisdictions, not so much. Of course, some jurisdictions impose a heeding presumption that requires rebuttal by the defendant. The standards differ, are elusive, and are sometimes incoherent. Assuming one grasps the nuances of the particular warning causation test in play, what are appropriate techniques and tactics to show that the plaintiff fails the test? Click here to register and view on demand.
MDL Trends | Presented by Blogger Eric Alexander and Jamie Lanphear | With more than 70 percent of the federal civil caseload residing in MDLs, it is important that companies and their counsel keep apprised of the recent trends coming out of MDL courts. In this session, the presenters review the most recent developments in this area, including the use (and non-use) of Lone Pine Orders, waves and remands, common rulings, secondary defendants, the impact of a co-defendant’s bankruptcy, and the use of census registries. Click here to register and view on demand.
Upon completing a program, please email Erin Guna at email@example.com with the titles of the sessions you viewed so Reed Smith can process your credit.